Organometallics
Article
2JHP = 14.4, 1H, CH (anti)), 2.35 (d, J = 13.2, 1H, CH (anti)), 1.56
2
(125.7 MHz, CDCl , δ(ppm), J (Hz)): 164.2 (q, J = 48.8 Hz, 4C,
3 CB
1
2
HP
2
13
1
2
2
(
s, 3H, CH (allyl)), 1.44 (s, 6H, CH ). C{ H} NMR (100.6 MHz,
CB(Ar)), 140.8 (d, J = 5.0, 1C, C(Ar)), 140.6 (d, J = 6.3, 1C,
3
3
CP CP
2
2
2
CDCl , δ (ppm), J (Hz)): 141.6 (d, J = 7.9, 1C, C(Ar)), 141.5 (d,
C(Ar)), 140.3 (d, J = 3.8, 1C, C(Ar)), 140.2 (d, J = 6.3, 1C,
CP CP
3
CP
2
2
2
C(Ar)), 137.9 (pt, 2JCP = 8.1, 1C, C(allyl)), 136.7−121.2 (56C,
2 2
JCP = 7.9, 1C, C(Ar)), 140.9 (d, J = 2.5, 1C, C(Ar)), 140.4 (d, J
CP
CP
2
=
2.5, 1C, C(Ar)), 135.3 (pt, J = 7.7, 1C, C(allyl)), 134.0−131.0
44CH(Ar) + 12C(Ar)), 80.4 (d, J = 2.5, 1C, OCH), 79.7 (d, J
=
CP
CP
CP
2
2
(
12C, C(Ar)), 130.0−121.0 (24C, CH(Ar)), 111.7 (s, 1C, O CMe ),
2
2
6.3, 1C, OCH), 67.0 (dd, J
= 39.4, J
= 4.4, 1C, CH (allyl)),
CPtrans
CPcis 2
3
2
7
6
8.3 (d, J = 7.4, 2C, OCH), 68.0 (d, J
= 38.3, 1C, CH (allyl)),
2
2
2
CP
CPtrans
2
66.4 (dd, J
= 40.6, J
= 4.4, 1C, CH (allyl)), 39.2 (d, J
=
CP
CPtrans
CPcis
2
6.9 (d, 2JCP = 14.1, 1C, OCH ), 65.2 (d, JCPtrans = 40.3, 1C,
2
2
2
2
7.5, 1C, CH (NMe)), 39.0 (d, J = 27.5, 1C, CH (NMe)), 36.2 (d,
2
2
3 CP 3
CH (allyl)), 40.4 (d, J = 13.1, 1C, CH (NMe), 40.1 (d, J = 14.0,
C, CH (NMe), 36.5 (d, J = 7.2, 1C, CH (NMe)), 36.3 (d, J
.8, 1C, CH (NMe)), 26.9 (s, 2C, CH ), 23.8 (s, 1C, CH (allyl)). HR-
2
2
2
CP
3
CP
JCP = 10.0, 1C, CH (NMe)), 35.9 (d, J = 10.0, 1C, CH (NMe)),
3.8 (s, 1C, CH (allyl)), 20.6 (d, J = 2.5, 1C, CH ), 20.2 (d, J
2
2
3
CP
3
1
=
3
CP
3
CP
3
3
2
=
3
CP
3
CP
7
3
3
3
+
+
2.5, 1C, CH ). HR-MS (ESI, m/z): calcd for C H N O P Pd
3 52 51 4 2 2
MS (ESI, m/z): calcd for C H N O P Pd 1003.2733, found
55
55
4
4 2
+
+
931.2522, found 931.2538 [M] .
2c-(R;R ;R). Yield: 69 mg (12%). Mp: 198−205 °C dec. P{ H}
NMR (121.4 MHz, CDCl , δ (ppm), J (Hz)): 151.1 (d, J = 67.0),
1
003.2733 [M] .
3
1
1
c-(R;S ;R). Yield: 158 mg (31%). Mp: 215−225 °C dec. 31P NMR
101.2 MHz, CDCl , 298 K, δ (ppm), J (Hz)): 149.9 (d, J = 65.8),
1
al
al
2
2
(
1
3
PP
3
PP
2
1
2
1
45.6 (d, J = 65.8). H NMR (500 MHz, CDCl , 298 K): 8.34−
149.7 (d, JPP = 67.0). H NMR (400 MHz, CDCl
3
, δ (ppm), J (Hz)):
PP
3
3
3
6
.93 (m, 34H, CH(Ar)), 5.84 (d, J = 7.5, 1H, CH(Ar)), 5.23 (d,
8.22−6.81 (om, 56H, CH(Ar)), 3.46 (d, JHP = 13.6, 3H, CH
3.24 (d, J = 14.0, 3H, CH (NMe)), 3.00 (bs, 1H, CH (syn)), 2.47
(bs, 1H, CH (anti)), 2.45 (bs, 1H, CH (anti)), 2.28 (bs, 1H,
2 2
CH (syn)), 1.71 (d, J = 10.4, 3H, CH (NMe)), 1.56 (d, J
10.4, 3H, CH (NMe)), 1.39 (s, 3H, CH (allyl)). C{ H} NMR
(125.7 MHz, CDCl , δ (ppm), J (Hz)): 164.4 (q, J = 48.8, 4C,
CB(Ar)), 146.1 (d, J = 1.3, 1C, C(Ar)), 146.0 (d, J = 2.5, 1C,
C(Ar)), 145.7 (bs, 1C, C(Ar)), 141.3 (d, J = 5.0, 1C, C(Ar)), 140.8
3
(NMe)),
HH
3
3
JHH = 7.5, 1H, CH(Ar)), 4.44 (bs, 1H, CH (syn)), 3.55 (bs, 1H,
CH (syn)), 3.30 (d, J = 9.6, 3H, CH (NMe)), 3.25 (d, J = 8.8,
H, CH (NMe)), 2.91 (d, J = 12.8, 1H, CH (anti)), 2.81 (d, J
2
HP
3
2
3
3
2
HP
3
HP
2
2
3
3
3
=
=
3
HP
2
HP
2
HP
3
HP
3
1
3
1
1
3.6, 1H, CH (anti)), 2.49 (d, J = 15.02 3H, CH (NMe)), 1.79 (d,
2 HP 3
3
3
3
13
1
JHP = 15.2, 3H, CH (NMe)), 1.70 (s, 3H, CH (allyl)). C{ H} NMR
1
3
3
3
2
CB
2
2
(
125.7 MHz, CDCl , δ (ppm), J (Hz)): 150.2 (d, J = 2.5, 1C,
3
C
P
CP
CP
2
2
C(Ar)), 149.4 (d, J = 6.3, 1C, C(Ar)), 141.4 (d, J = 3.8, 1C,
C(Ar)), 140.8 (d, J = 3.8, 1C, C(Ar)), 139.8 (d, J = 7.5, 1C,
C(Ar)), 139.3 (d, J = 7.5, 1C, C(Ar)), 138.0 (pt, JCP = 7.5, 1C,
C(allyl)), 133.9−121.5 (54C, 18C(Ar) + 36CH(Ar)), 72.8 (d, J
2
CP
CP
CP
2
2
2
2
CP
CP
(
d, J = 5.0, 1C, C(Ar)), 140.2 (d, J = 7.5, 1C, C(Ar)), 140.0 (d,
JCP = 7.5, 1C, C(Ar)), 138.5 (pt, J = 7.5, 1C, C(allyl)), 136.5−
2
CP CP
CP
2
2
2
CP
CPtrans
2
2
2
111.8 (73C, 17C(Ar) + 56CH(Ar)), 77.5 (dd, JCPtrans = 37.5, JCPcis =
=
(
38.8, 1C, CH (allyl)), 68.2 (d, J
= 37.5, 1C, CH (allyl)), 40.0
2
CPtrans 2
1.3, 1C, CH (allyl)), 68.5 (dd, JCPtrans= 37.5, 2JCPcis = 1.3, 1C,
2
2
4
2
2
dd, J = 33.1, J = 3.1, 1C, CH (NMe)), 38.3 (d, J = 32.5, 1C,
CP CP 3 CP
2
2
CH (allyl)), 40.2 (bs, 1C, CH (NMe)), 40.0 (bs, 1C, CH (NMe)),
2 3 3
CH (NMe)), 37.5 (d, J = 12.6, 1C, CH (NMe)), 37.4 (d, J =
.8, 1C, CH (NMe)), 23.1 (s, 1C, CH (allyl)). HR-MS (ESI, m/z):
3
CP
3
CP
2
3
4.6 (pt, J = 13.0, 2C, CH (NMe)), 22.4 (s, 1C, CH (allyl)). HR-
8
CP 3 3
3
3
+
+
+
calcd for C H N O P Pd 1127.2835, found 1127.2843 [M] .
MS (ESI, m/z): calcd for C68
1127.2832 [M] .
H
55
N
4
O
2
P
2
Pd 1127.2835, found
6
8
55
4
2 2
1
c-(R;R ;R). Yield: 168 mg (33%). Mp: 260−263 °C dec. 1P NMR
3
+
al
2
(
1
6
161.9 MHz, CDCl , 298 K, δ (ppm), J (Hz)): 152.3 (d, J = 66.4),
General Procedure for Pd-Catalyzed Allylic Substitutions of
rac-I. Allylic Alkylation. Reactions were carried out in a Schlenk tube
under N at 25 °C. A 0.01 mmol amount of the palladium complex
3
PP
2
1
49.7 (d, J = 66.4). H NMR (400 MHz, CDCl , 298 K): 8.25−
PP
3
3
.81 (m, 36H, CH(Ar)), 3.49 (d, J = 13.6, 3H, CH (NMe)), 3.26
HP
3
2
3
(
d, J = 13.6, 3H, CH (NMe)), 2.96 (bs, 1H, CH (syn)), 2.49 (bs,
(1a−c, 2a, or 2c) was dissolved in 8 mL of CH Cl . Then, 1 mmol of
HP
3
2
2
2
1
1
H, CH (anti)), 2.46 (bs, 1H, CH (anti)), 2.30 (bs, 1H, CH (syn)),
2
2
2
rac-3-acetoxy-1,3-diphenyl-1-propene and 1.5 mmol of Na(CH-
3
3
.71 (d, J = 10.8, 3H, CH (NMe)), 1.56 (d, J = 10.4, 3H,
CH (NMe)), 1.41 (s, 3H, CH (allyl)). C{ H} NMR (100.6 MHz,
CDCl , δ (ppm), J (Hz)): 146.3 (bs, 1C, C(Ar)), 146.2 (bs, 1C,
C(Ar)), 141.5 (d, J = 4.0, 1C, C(Ar)), 141.0 (d, J = 4.3, 1C,
C(Ar)), 140.5 (d, J = 7.9, 1C, C(Ar)), 140.1 (d, J = 7.4, 1C,
C(Ar)), 137.5 (pt, JCP = 7.6, 1C, C(allyl)), 134.0−119.4 (54C,
CPtrans 2
d, JCPtrans = 37.4, 1C, CH (allyl)), 40.4 (d, JCP = 5.2, 1C,
HP
3
HP
(COOMe) ) were added to the solution. The mixture was stirred at
2
13
1
3
3
room temperature for 24 h. At the end of the reaction, the mixture was
diluted with diethyl ether and washed with ammonium chloride
solution (3 × 10 mL) and water (2 × 10 mL). The organic phase was
dried over anhydrous Na SO and filtered off. After partially removing
the solvent under reduced pressure, the solution was eluted through a
short silica column with ethyl acetate. Conversions were determined
by H NMR. Enantiomeric excesses were determined by HPLC on a
Chiralcel-OD-H chiral column, using hexane/2-propanol = 95/5 as
eluent and a flow rate of 0.5 mL/min.
Allylic Amination. The procedure was analogous to that described
for allylic alkylation, using 3 mmol of benzylamine as nucleophile and
4 mL of CH Cl . Conversions and enantiomeric excesses were
determined by HPLC on a Chiralcel-OD-H chiral column, using
hexane/2-propanol = 99/1 as eluent and a flow rate of 0.3 mL/min.
General Procedure for Rh-Catalyzed Hydroformylation of
Styrene. A solution was prepared in a Schlenk flask dissolving
3
2
2
CP
CP
2
2
CP
CP
2
4
2
1
(
8C(Ar) + 36CH(Ar)), 77.2 (d, J
= 38.8, 1C, CH (allyl)), 68.8
2
2
2
1
2
2
CH (NMe)), 40.1 (d, J = 9.4, 1C, CH (NMe)), 34.6 (d, J =
3
CP
3
CP
2
1
1
1
3.1, 1C, CH (NMe)), 34.5 (d, J = 13.7, 1C, CH (NMe)), 22.3 (s,
3 CP 3
+
C, CH (allyl)). HR-MS (ESI, m/z): calcd for C H N O P Pd
3
68 55
4
2 2
+
127.2835, found 1127.2839 [M] .
General Procedure for the Synthesis of [Pd(η -2-Me-
C H )(P−P)]BPh (2a,c). To a solution of diamidophosphite a-
3
3
4
4
2
2
(
R;S ,S ;R) or c-(R;R ;R) (0.40 mmol) in toluene (10 mL) at 0 °C
al al al
3
was added dropwise a solution of [Pd(η -2-Me-C H )(μ-Cl)] (79 mg,
3
4
2
0
0
.20 mmol) in CH Cl (5 mL). Then a solution of NaPF (67 mg,
2
2
6
.40 mmol) in THF (5 mL) was added. After 1 h of stirring at room
temperature, a solution of NaBPh (204 mg, 0.60 mmol) in 20 mL of
MeOH was added. The white solid formed on standing was filtered off
and washed with deoxygenated water.
4
[
Rh(acac)(CO) ] (5.2 mg, 0.02 mmol), the corresponding ligand
0.04 mmol), 20.0 mmol of substrate, and 300 μL of n-dodecane as
2
(
internal standard in dry and degassed toluene up to a volume of 10
mL. The solution was transferred to a Parr autoclave. This was charged
to 20 bar of syn-gas and heated to the required temperature, while the
mechanical stirring was kept at 700 rpm. At the end of the reaction the
conversion and selectivity were analyzed by GC, while the ee was
analyzed by GC, using a Supelcoβ-Dex 120 chiral column, after
oxidation of the aldehydes to the corresponding carboxylic acids with
KMnO /MgSO in acetone. The [RhH(CO) (c-(R;Sal;R)] complex
was prepared in a Fischer−Porter tube, by reacting [Rh(acac)(η -
C H ) ] with 1 equiv of the ligand in CO/H atmosphere.
2
a-(R;S ,S ;R). Yield: 125 mg (25%). Mp: 174−177 °C dec.
al al
3
1
1
2
P{ H} NMR (101.2 MHz, CDCl , δ (ppm), J (Hz)): 139.4 (d, J
=
PP
3
2
1
9
(
4.9), 135.7 (d, J = 94.9). H NMR (500 MHz, CDCl , δ (ppm), J
P
P
3
Hz)): 8.05−6.75 (om, 44H, CH(Ar)), 4.87 (m, 1H, OCH), 4.60 (m,
2
2
1
1
H, OCH), 3.72 (bd, J = 7.0, 1H, CH (syn)), 3.32 (bd, J = 7.5,
HP 2 HP
3
3
H, CH (syn)), 3.15 (d, J = 14.5, 3H, CH (NMe)), 3.00 (d, J =
2
HP
3
HP
3
9
.5, 3H, CH (NMe)), 2.98 (d, J = 14.5, 3H, CH (NMe)), 2.92 (d,
3 HP 3
3
2
JHP = 9.5, 3H, CH (NMe)), 2.68 (d, J = 13.5, 1H, CH (anti)),
.49 (d, J = 13.5, 1H, CH (anti)), 1.58 (s, 3H, CH (allyl)), 1.47 (d,
JHH = 6.5, 3H, CH ), 1.43 (d, J = 6.5, 3H, CH3). C{ H} NMR
4
4
2
3
HP
2
2
2
2
HP
2
3
3
3
13
1
3
HH
2
4
2
2
H
Organometallics XXXX, XXX, XXX−XXX